Organon & Co.: Asthma trials

The registry lists 59 Asthma studies with Organon & Co. as lead sponsor. 0 are open to participants now and 35 have results posted.

Phase 1 2Phase 2 5Phase 3 34Phase 4 16No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)CompletedNCT02741271Phase 3Results posted
• Study of Mometasone Furoate/Formoterol Fumarate (MF/F) Metered Dose Inhaler (MDI) in Adolescents & Adults With Persistent Asthma (P08212)CompletedNCT01566149Phase 3Results posted
• A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)CompletedNCT01502371Phase 2Results posted
• A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)CompletedNCT01471340Phase 4Results posted
• A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)CompletedNCT01258803Phase 2Results posted
• Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )CompletedNCT00968201Phase 3Results posted
• Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)CompletedNCT00943683Not applicableResults posted
• Extended Safety Study of Montelukast in Infants and Young Children With Chronic Asthma (0476-232)CompletedNCT00943397Phase 3Results posted
• The Clinical Effect of MK0476 With Concomitant Administration of and Removal of Inhaled Beclomethasone in Asthmatic Patients (0476-029)CompletedNCT00911547Phase 3Results posted
• Pediatric ACTION3 (Identify, Treat, Control): Effectiveness of Adding Montelukast in Pediatric Subjects With Uncontrolled Asthma (0476-385)CompletedNCT00832455Phase 4Results posted
• The Safety and Effectiveness of MK0476 (Montelukast) in Patients With Chronic Asthma (0476-388)CompletedNCT00739297Phase 1Results posted
• Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)CompletedNCT00666679Phase 2Results posted
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)CompletedNCT00636207Phase 1Results posted
• Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)CompletedNCT00635882Phase 2Results posted
• A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)CompletedNCT00604500Phase 3Results posted
• An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent AsthmaCompletedNCT00599027Phase 3Results posted
• Singulair(R) In Asthma And Allergic Rhinitis (0476-383)CompletedNCT00545844Phase 4Results posted
• A Study of the Equivalent Effectiveness of 400 mcg Mometasone Furoate Using Two Different Dry Powder Inhalers in Moderate Asthmatics (Study P04828)CompletedNCT00521599Phase 4Results posted
• Montelukast Back to School Asthma Study (0476-340)CompletedNCT00461032Phase 3Results posted
• Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED)TerminatedNCT00442351Phase 4Results posted
• Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)CompletedNCT00442338Phase 3Results posted
• A Comparison of Mometasone Furoate DPI Versus Budesonide DPI in Budesonide DPI in Asthmatics (Study P04880)CompletedNCT00442117Phase 3Results posted
• Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)CompletedNCT00424008Phase 3Results posted
• Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)CompletedNCT00394355Phase 4Results posted
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)CompletedNCT00383552Phase 3Results posted
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04334AM1)(COMPLETED)CompletedNCT00383240Phase 3Results posted
• Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04431AM2)(COMPLETED)CompletedNCT00381485Phase 3Results posted
• Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (P04139)CompletedNCT00379288Phase 3Results posted
• Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)CompletedNCT00337675Phase 3Results posted
• Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)CompletedNCT00289874Phase 3Results posted
• Montelukast Asthmatic Smoker Study (0476-332)(COMPLETED)CompletedNCT00284856Phase 3Results posted
• MK0476 Study in Adult Patients With Acute Asthma (0476-322)CompletedNCT00229970Phase 3Results posted
• Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911)CompletedNCT00127166Phase 3Results posted
• A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)CompletedNCT00117338Phase 3Results posted
• Nasonex Compared With Placebo in Participants With Seasonal Allergic Rhinitis (SAR) and Concomitant Asthma (P03280)CompletedNCT00070707Phase 4Results posted
• Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)WithdrawnNCT01615874Phase 2
• Efficacy and Safety of Mometasone Furoate for Persistent Asthma Previously Treated With Low-Dose Inhaled Glucocorticosteroids (ICS) (Study P06115)WithdrawnNCT01026870Phase 3
• A Randomized Trial Assessing Once Daily Administration of Mometasone Furoate DPI in Asthmatics (Study P02177)CompletedNCT00835094Phase 4
• A Study to Determine the Efficacy and Safety of Two Mometasone Dry Powder Inhalers in the Treatment of Asthma (Study P02524)CompletedNCT00817817Phase 3
• Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Hayfever With or Without Asthma (P03472)CompletedNCT00805324Phase 3
• Montelukast in Chronic AsthmaCompletedNCT00802789
• Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396)CompletedNCT00756418Phase 4
• The Singulair® add-on Study Effectiveness of Adding Montelukast to Inhaled Corticosteroids in Adult Subjects With Uncontrolled Asthma (0476-384)CompletedNCT00755794Phase 3
• A Study of MK0476 in the Treatment of Asthma Patients Aged 2-5 Years (0476-907)CompletedNCT00700661Phase 3
• First Step With Singulair® Therapy (0476-323)CompletedNCT00545324Phase 4
• A Study of Montelukast (MK-0476) Compared With Fluticasone in Pediatric Participants With Chronic Asthma (MK-0476-303)WithdrawnNCT00540839Phase 3
• A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)CompletedNCT00489346Phase 3
• Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)CompletedNCT00446056Phase 4
• SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)CompletedNCT00445107Phase 3
• To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366)CompletedNCT00398151Phase 3
• Linear Growth Study (0476-097)(COMPLETED)CompletedNCT00395408Phase 4
• Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)CompletedNCT00380705Phase 4
• A Study to Assess the Effect of Montelukast Sodium With Concomitant Administration of Inhaled Budesonide in Asthmatic Patients (0476-075)CompletedNCT00140946Phase 4
• A Study to Determine the Effect of Montelukast Sodium as an Episode Modifier in the Treatment of Infrequent Episodic Asthma in Children (0476-165)CompletedNCT00140881Phase 4
• Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288)CompletedNCT00092989Phase 3
• An Approved Drug to Study a New Indication for Seasonal Allergic Rhinitis in Patients With Asthma (0476-269)CompletedNCT00092885Phase 3
• Study of an Approved Drug in Patients With Asthma (0476-289)(COMPLETED)CompletedNCT00092144Phase 3
• Study of MK0476 (Montelukast Sodium) and Effects on Asthma and Nasal Symptoms Upon Exposure to Cats (0476-256)CompletedNCT00092105Phase 3
• Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254)CompletedNCT00092092Phase 4